Fig. 3

OEPC aggregates containing VEGF-MPs improve in vivo survival. OEPC aggregates were prepared with sVEGF, blank MPs or VEGF-MPs and implanted subcutaneously. a Representative IVIS images and b fluorescence intensity measurements of mice following injection of cell aggregates containing 1 million GFP-labeled OEPCs with sVEGF, blank MPs, or VEGF-MPs. The fluorescence intensities were normalized by day one. Results are average ± SEM (n = 7)